Replies to post #184 on Novartis (NVS)

[urche]

That Seeking Alpha article seems to have another agenda, IMO.

I can't argue that NVS has threats looming to its pipeline. But, it seems preposterous to me to posit that an OTC drug from a tiny company poses a serious threat to NVS in general and Diovan in particular. This article seems more a way to promote "Chromadex Corporation's (CDXC.OB) patented pTeroPure® (pterostilbene)" than downplay the NVS pipeline with any credibility.

[OCKHAM'S RAZOR]

I dont care what the article says...NVS going up for some reason.